NCT03498092View on ClinicalTrials.gov

Dexmedetomidine in Serratus Plane Block for Mastectomy

NACompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

August 8, 2016

Primary Completion Date

October 8, 2018

Study Completion Date

October 8, 2018

Conditions
Postoperative Pain
Interventions
DRUG

Bupivacaine-Dexmedetomidine

isobaric bupivacaine 2.5 mg/ml plus 5 micro gram/ml adrenaline and 1 micro gram/kg dexmedetomidine in a volume of 0.5 ml/kg

DRUG

Bupivacaine

isobaric bupivacaine 2.5 mg/ml plus 5 micro gram/ml adrenaline in a volume of 0.5 ml/kg

DRUG

General anesthesia

Normal saline in a volume of 0.5 ml/kg

Trial Locations (1)

35516

Oncology Center Mansoura University., Al Mansurah

All Listed Sponsors
lead

Alaa Mazy

OTHER

NCT03498092 - Dexmedetomidine in Serratus Plane Block for Mastectomy | Biotech Hunter | Biotech Hunter